Profilin-1 Expression Is Associated with High Grade and Stage and Decreased Progression-Free Survival in Renal Cell Carcinoma

被引：0
|
作者：
Karamchandani, J. R.
White, N. M. A.
Scorilas, A.
Gabril, M. Y.
Filter, E.
Yousef, G. M.
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[3] Univ Athens, Athens, Greece
[4] London Hlth Sci, London, ON, Canada
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
982
引用
收藏
页码：239A / 239A
页数：1
相关论文
共 50 条
  • [1] Profilin-1 Expression Is Associated with High Grade and Stage and Decreased Progression-Free Survival in Renal Cell Carcinoma
    Karamchandani, J. R.
    White, N. A. M.
    Scorilas, A.
    Gabril, M. Y.
    Filter, E.
    Yousef, G. M.
    [J]. MODERN PATHOLOGY, 2014, 27 : 239A - 239A
  • [2] Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma
    Karamchandani, Jason R.
    Gabril, Manal Y.
    Ibrahim, Rania
    Scorilas, Andreas
    Filter, Emily
    Finelli, Antonio
    Lee, Jason Y.
    Ordon, Michael
    Pasic, Maria
    Romaschin, Alexander D.
    Yousef, George M.
    [J]. HUMAN PATHOLOGY, 2015, 46 (05) : 673 - 680
  • [3] Progression-free survival 'doubles' in renal cell carcinoma
    Fricker, Janet
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (10) : 555 - 555
  • [4] PHD3 expression is a predictor of progression-free survival in clear cell renal cell carcinoma
    Tanaka, T.
    Kitamura, H.
    Torigoe, T.
    Hirohashi, Y.
    Masumori, N.
    Sato, N.
    Tsukamoto, T.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E199 - U615
  • [5] Mayo Adhesive Probability Score Is Associated With Localized Renal Cell Carcinoma Progression-free Survival
    Thiel, David D.
    Davidiuk, Andrew J.
    Meschia, Camille
    Serie, Daniel
    Custer, Kaitlynn
    Petrou, Steven P.
    Parker, Alexander S.
    [J]. UROLOGY, 2016, 89 : 54 - 60
  • [6] Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma
    Hotte, S. J.
    Bjarnason, G. A.
    Heng, D. Y. C.
    Jewett, M. A. S.
    Kapoor, A.
    Kollmannsberger, C.
    Maroun, J.
    Mayhew, L. A.
    North, S.
    Reaume, M. N.
    Ruether, J. D.
    Soulieres, D.
    Venner, P. M.
    Winquist, E. W.
    Wood, L.
    Yong, J. H. E.
    Saad, F.
    [J]. CURRENT ONCOLOGY, 2011, 18 : S11 - S19
  • [7] Nexavar® improves progression-free survival of patients with advanced renal cell carcinoma
    Schäfer, H
    [J]. ONKOLOGIE, 2006, 29 (05): : 233 - 233
  • [8] Mayo Adhesive Probability Score Is Associated With Localized Renal Cell Carcinoma Progression-free Survival REPLY
    Thiel, David D.
    Davidiuk, Andrew J.
    Meschia, Camille
    Serie, Daniel
    Custer, Kaitlynn
    Petrou, Steven P.
    Parker, Alexander S.
    [J]. UROLOGY, 2016, 89 : 61 - 62
  • [9] A loss of profilin-1 in late-stage oral squamous cell carcinoma
    Adami, Guy R.
    O'Callaghan, Thomas N.
    Kolokythas, Antonia
    Cabay, Robert J.
    Zhou, Yalu
    Schwartz, Joel L.
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2017, 46 (07) : 489 - 495
  • [10] Progression-Free Survival as a Surrogate Endpoint of Overall Survival in Patients With Metastatic Renal Cell Carcinoma
    Halabi, Susan
    Rini, Brian
    Escudier, Bernard
    Stadler, Walter M.
    Small, Eric J.
    [J]. CANCER, 2014, 120 (01) : 52 - 60
12345